Fig. 3From: Therapeutic potential of mesenchymal stem/stromal cells (MSCs)-based cell therapy for inflammatory bowel diseases (IBD) therapyClinical trials based on MSCs therapy in IBD conditions registered on https://clinicaltrials.gov (June 2022). The schematic exhibits the clinical studies in the light of cell source (A), cell type (B), administration route (C), condition (D), study phase (E), and study location (F). Inflammatory bowel diseases (IBD), mesenchymal stem/stromal cell (MSC), bone marrow (BM), umbilical cord (UC), adipose tissue (AT), Wharton's jelly (WJ), Crohn's disease (CD), ulcerative colitis (UC), not applicable (NA)Back to article page